Impact of methodological choices in comparative effectiveness studies: application in natalizumab versus fingolimod comparison among patients with multiple sclerosis
Abstract Background Natalizumab and fingolimod are used as high-efficacy treatments in relapsing–remitting multiple sclerosis. Several observational studies comparing these two drugs have shown variable results, using different methods to control treatment indication bias and manage censoring. The o...
Similar Items
-
DOENÇA HEMOLITICA PERI NATAL (DHPN) GRAVE SECUNDÁRIA A ALOIMUNIZAÇÃO POR ANTI-RH17
by: M.M.O. Barros, et al.
Published: (2020-11-01) -
Información Bibliográfica
by: G. C.V., et al.
Published: (2001-04-01) -
LEUCEMIA MIELOIDE CRÔNICA REFRATÁRIA – PRESENÇA DE MUTAÇÃO T315I E RESPOSTA A PONATINIBE
by: J.M.T.P.D. Nascimento, et al.
Published: (2020-11-01) -
Proposal of a Novel Criteria for Soil Corrosivity Evaluation and the Development of New Soil Synthetic Solutions for Laboratory Investigations
by: J. M. Giarola, et al.
Published: (2022-02-01) -
DESIGN OF A FREE AND OPEN SOURCE DATA PROCESSING, ARCHIVING, AND DISTRIBUTION SUBSYSTEM FOR THE GROUND RECEIVING STATION OF THE PHILIPPINE SCIENTIFIC EARTH OBSERVATION MICRO-SATELLITE
by: R. K. D. Aranas, et al.
Published: (2016-06-01)